Life Stem Genetics Inc. (LIFS) Research

Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.

Market snapshot

Symbol
LIFS
Price
$0.00
Day change
0.00%
Market cap
$4.6K
P/E ratio
-2.38x
52-week range
0.0001-0.0003
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Aridis Pharmaceuticals, Inc. (ARDS)
  • Biostax Corp. (BTAX)
  • Capital Group Holdings, Inc. (CGHC)
  • Evelo Biosciences, Inc. (EVLO)
  • HEALTHeUNIVERSE, Inc. (HLUN)
  • HST Global, Inc. (HSTC)
  • Ingen Technologies, Inc. (IGNT)
  • Infinity Pharmaceuticals, Inc. (INFIQ)

Open Life Stem Genetics Inc. (LIFS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.